G

Genfit SA

GNFT

4.25000
USD
0.1
(2.41%)
مفتوح الان
حجم التداول
3
الربح لكل سهم
0
العائد الربحي
0
P/E
15
حجم السوق
294,947,315
أصول ذات صلة
AAPL
-3.610
(-1.63%)
218.370 USD
AMZN
-3.000
(-1.60%)
183.990 USD
DIS
-0.640
(-0.68%)
93.050 USD
GOOGL
-0.710
(-0.41%)
170.760 USD
MSFT
-1.14
(-0.27%)
417.07 USD
NFLX
-3.53
(-0.56%)
624.46 USD
NVDA
-7.750
(-6.62%)
109.380 USD
SPOT
-7.39
(-2.15%)
336.59 USD
TSLA
-15.150
(-6.53%)
216.890 USD
الأخبار المقالات

العنوان: Genfit SA

القطاع: Healthcare
الصناعة: Biotechnology
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.